Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Colorectal Neoplasms 7 Neoplasms 4 Breast Neoplasms 4 Recurrence 3 Colonic Neoplasms 3 Rectal Neoplasms 2 Neoplasm Metastasis 2 Tuberous Sclerosis 1 Seizures 1 Rectal Diseases 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplastic Cells, Circulating 1 Neoplasms by Site 1 Nasopharyngeal Carcinoma 1 NSCLC 1 Multiple Myeloma 1 Lung Neoplasms 1 Intestinal Neoplasms 1 Intestinal Diseases 1 Inflammation 1 Gastrointestinal Neoplasms 1 Gastrointestinal Hemorrhage 1 Gastrointestinal Diseases 1 Epilepsy 1 Digestive System Neoplasms 1 Digestive System Diseases 1 Colonic Diseases 1 Cognitive Dysfunction 1 Carcinoma, Squamous Cell 1

Interventions

Cisplatin 10 Paclitaxel 9 Radiotherapy 5 Fluorouracil 5 Radiotherapy, Intensity-Modulated 4 Docetaxel 4 Carboplatin 4 advexin 2 Therapeutics 2 Surveys and Questionnaires 2 Oxaliplatin 2 Leucovorin 2 Drug Therapy 2 Cetuximab 2 Afatinib 2 penpulimab 1 pembrolizumab 1 olaparib 1 niraparib 1 nimotuzumab 1 nedaplatin 1 durvalumab 1 daromun 1 camrelizumab 1 calcipotriene 1 atezolizumab 1 afamelanotide 1 TP protocol 1 Surgical Procedures, Operative 1 Radiotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Carcinoma, Squamous Cell × Aspirin × Clear all

NCT01496521 2011-12-21

CREAT

Beijing Friendship Hospital

Phase 3 Unknown

Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡